$719.51
0.93% day before yesterday
NYSE, May 30, 10:12 pm CET
ISIN
US58155Q1031
Symbol
MCK

McKesson Stock price

$719.51
+6.72 0.94% 1M
+98.22 15.81% 6M
+149.60 26.25% YTD
+158.55 28.26% 1Y
+384.55 114.80% 3Y
+560.57 352.69% 5Y
+481.24 201.97% 10Y
NYSE, Closing price Fri, May 30 2025
+6.65 0.93%
ISIN
US58155Q1031
Symbol
MCK
Sector

Key metrics

Market capitalization $90.02b
Enterprise Value $89.98b
P/E (TTM) P/E ratio 27.49
EV/FCF (TTM) EV/FCF 17.22
EV/Sales (TTM) EV/Sales 0.25
P/S ratio (TTM) P/S ratio 0.25
P/B ratio (TTM) P/B ratio negative
Dividend yield 0.38%
Last dividend (FY25) $2.75
Revenue growth (TTM) Revenue growth 16.22%
Revenue (TTM) Revenue $359.05b
EBIT (operating result TTM) EBIT $5.03b
Free Cash Flow (TTM) Free Cash Flow $5.23b
Cash position $5.69b
EPS (TTM) EPS $26.17
P/E forward 20.44
P/S forward 0.22
EV/Sales forward 0.22
Short interest 1.69%
Show more

Is McKesson a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

McKesson Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a McKesson forecast:

14x Buy
74%
4x Hold
21%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a McKesson forecast:

Buy
74%
Hold
21%
Sell
5%

Financial data from McKesson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
359,051 359,051
16% 16%
100%
- Direct Costs 346,177 346,177
17% 17%
96%
12,874 12,874
2% 2%
4%
- Selling and Administrative Expenses 7,841 7,841
10% 10%
2%
- Research and Development Expense - -
-
-
5,669 5,669
24% 24%
2%
- Depreciation and Amortization 636 636
0% 0%
0%
EBIT (Operating Income) EBIT 5,033 5,033
28% 28%
1%
Net Profit 3,295 3,295
10% 10%
1%

In millions USD.

Don't miss a Thing! We will send you all news about McKesson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

McKesson Stock News

Positive
Seeking Alpha
14 days ago
The stock price of McKesson has maintained a strong upward trend throughout multiple years because of its solid financial performance and dedicated investor support which creates a defensive investment opportunity. The company achieves strong revenue and EPS growth through its expanding oncology, biopharmaceutical and GLP-1 therapy sales, which counterbalance the typical thin margins of the sec...
Positive
Seeking Alpha
15 days ago
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate quantitatively and qualitatively, and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth qu...
Positive
Forbes
17 days ago
Deal OverviewOn May 8, 2025, McKesson Corporation (NYSE: MCK, $682.28, Market Capitalization: $85.4 billion), a diversified healthcare services company, announced its intention to separate its Medical-Surgical Solutions segment into an independent company (NewCo) (for more information, visit spinoffresearch.com). McKesson is committed to exploring all opportunities to execute a separation in a ...
More McKesson News

Company Profile

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Head office United States
CEO Brian Tyler
Employees 48,000
Founded 1833
Website www.mckesson.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today